These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma. Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228 [TBL] [Abstract][Full Text] [Related]
9. Outcome and prognostic factors of 391 Japanese patients with primary sclerosing cholangitis. Tanaka A; Takamori Y; Toda G; Ohnishi S; Takikawa H Liver Int; 2008 Aug; 28(7):983-9. PubMed ID: 18397233 [TBL] [Abstract][Full Text] [Related]
10. Cholangiocarcinoma in young individuals with and without primary sclerosing cholangitis. Björnsson E; Angulo P Am J Gastroenterol; 2007 Aug; 102(8):1677-82. PubMed ID: 17433022 [TBL] [Abstract][Full Text] [Related]
11. Alkaline phosphatase normalization is a biomarker of improved survival in primary sclerosing cholangitis. Hilscher M; Enders FB; Carey EJ; Lindor KD; Tabibian JH Ann Hepatol; 2016; 15(2):246-53. PubMed ID: 26845602 [TBL] [Abstract][Full Text] [Related]
12. [Cholangiocarcinoma in primary sclerosing cholangitis: "chronicle of a death foretold"?]. Margalit M; Elinav H; Goldin E; Ilan Y Harefuah; 2003 Jun; 142(6):421-5, 486. PubMed ID: 12858825 [TBL] [Abstract][Full Text] [Related]
13. Short-term prognostic factors for primary sclerosing cholangitis. Watanabe T; Hirano K; Tada M; Isayama H; Mizuno S; Arizumi T; Toda N; Sugawara Y; Kokudo N; Koike K J Hepatobiliary Pancreat Sci; 2015 Jun; 22(6):486-90. PubMed ID: 25826613 [TBL] [Abstract][Full Text] [Related]
14. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study. Bergquist A; Glaumann H; Persson B; Broomé U Hepatology; 1998 Feb; 27(2):311-6. PubMed ID: 9462625 [TBL] [Abstract][Full Text] [Related]
15. Liver transplantation for cholangiocarcinoma: selection is essential for acceptable results. Friman S; Foss A; Isoniemi H; Olausson M; Höckerstedt K; Yamamoto S; Karlsen TH; Rizell M; Ericzon BG Scand J Gastroenterol; 2011 Mar; 46(3):370-5. PubMed ID: 21073376 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of curcumin in primary sclerosing cholangitis: an open label pilot study. Eaton JE; Nelson KM; Gossard AA; Carey EJ; Tabibian JH; Lindor KD; LaRusso NF Scand J Gastroenterol; 2019 May; 54(5):633-639. PubMed ID: 31131678 [No Abstract] [Full Text] [Related]
17. Hepatobiliary and extra-hepatic malignancies in primary sclerosing cholangitis. Bergquist A; Broomé U Best Pract Res Clin Gastroenterol; 2001 Aug; 15(4):643-56. PubMed ID: 11492973 [TBL] [Abstract][Full Text] [Related]
18. Primary sclerosing cholangitis and cholangiocarcinoma: pathogenesis and modes of diagnostics. Ehlken H; Schramm C Dig Dis; 2013; 31(1):118-25. PubMed ID: 23797133 [TBL] [Abstract][Full Text] [Related]
19. Elevated Serum Bilirubin Level Correlates With the Development of Cholangiocarcinoma, Subsequent Liver Transplantation, and Death in Patients With Primary Sclerosing Cholangitis. Haseeb A; Siddiqui A; Taylor LJ; Cox K; Adler DG J Clin Gastroenterol; 2016; 50(5):431-5. PubMed ID: 26927495 [TBL] [Abstract][Full Text] [Related]
20. Screening and diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis. Jesudian AB; Jacobson IM Rev Gastroenterol Disord; 2009; 9(2):E41-7. PubMed ID: 19668124 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]